VARSHA V GANDHI to Risk Assessment
This is a "connection" page, showing publications VARSHA V GANDHI has written about Risk Assessment.
Connection Strength
0.016
-
Oral clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome. J Clin Oncol. 2010 Jun 01; 28(16):2755-60.
Score: 0.009
-
Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies. J Clin Oncol. 2005 May 20; 23(15):3396-403.
Score: 0.007